Back to News
Market Impact: 0.25

SK Hynix Has Traded at a Discount to Micron for Years. That May Be Changing.

MU
NDAQ
NFLX
NVDA
SKHY
SKHYV
TSTS
Artificial IntelligenceTechnology & InnovationCompany FundamentalsInvestor Sentiment & PositioningTechnology & Innovation
SK Hynix Has Traded at a Discount to Micron for Years. That May Be Changing.

SK Hynix (Nasdaq: SKHY) made its U.S. debut on July 10, raising $26.5B—the largest foreign listing in the U.S.—highlighting strong AI/data-center demand for memory and storage. The article argues SKHY’s historical valuation discount versus Micron may narrow as U.S. accessibility and index inclusion attract more institutional flows, though investors face concentration risks (notably revenue tied to Nvidia and DRAM). Near-term trading may be volatile post-listing, suggesting a gradual entry rather than an immediate lump-sum purchase.

Analysis

The market mechanism here is access, not a step-function change in fundamentals. A newly liquid U.S. listing can force a fast re-rating as U.S. multi-asset funds, quant models, and retail flows can finally own the name directly; that can compress the valuation gap versus U.S.-listed memory peers over the next 2-6 weeks. The second-order effect is broader sympathy for the memory complex, but the real beneficiary is whichever name best trades as the cleanest AI memory proxy rather than whichever has the best near-term earnings.

The risk is that investors confuse structural AI demand with a cyclical memory upcycle. Memory is still a pricing business; if HBM/DRAM ASPs plateau or peers add capacity, the multiple can compress quickly even while AI demand stays healthy. Falsifiers to watch over 1-3 months are weak post-listing liquidity, SKHY underperforming MU despite similar AI exposure, or guidance that implies mix shifts away from the highest-margin AI products. Over 6-18 months, the bigger danger is that this becomes a late-cycle sentiment trade rather than a durable earnings re-rate.

Contrarianly, the consensus may be underestimating how little the U.S. debut changes intrinsic value and overestimating how much it changes portfolio access. The best risk/reward is likely relative value, not outright beta: own the newly accessible name only if the spread to U.S. peers remains meaningful after the initial flow window. If the valuation gap closes too fast, that is a signal to fade enthusiasm rather than chase it.